Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation.
The proliferative activity of gastric cancer cells with endocrine features was evaluated in five cases by means of a double-immunostaining procedure. The endocrine cells were recognized by a monoclonal antibody to chromogranin A (CGA) and the proliferative activity by a monoclonal antibody to proliferating cell nuclear antigen (PCNA). With the use of two different chromogens it was easy to determine whether CGA was located in the cytoplasm and whether PCNA was located in the nucleus of the same section. The CGA-positive endocrine cells of the normal gastric antral mucosa could be readily distinguished from the PCNA-positive cells scattered in the mucosal neck zones. Over 1,000 CGA-positive cancer cells were counted per case. A few cells (average, less than 1.0%) exhibited faint nuclear staining with anti-PCNA; in no instance was unequivocal PCNA reactivity demonstrable in the gastric cancer cells with endocrine differentiation. By contrast, the PCNA reaction was positive in one fourth to one third of the other cancer cells. These observations suggest that gastric cancer cells with endocrine features are differentiated and do not participate in the cell cycle.
Ooi
A
A
Department of Pathology, Kanazawa University, Japan.
Hayashi
H
H
Katsuda
S
S
Nakanishi
I
I
D002455:Cell Division; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis*; D006801:Humans; D007124:Immunoenzyme Techniques; D009687:Nuclear Proteins / Q000032:analysis*; D018809:Proliferating Cell Nuclear Antigen; D013274:Stomach Neoplasms / Q000737:chemistry* / Q000473:pathology*
D053379:Chromogranin A; D002864:Chromogranins; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen